Biological Drug Api Manufacturing Market Report

Europe Biological Drug Api Manufacturing Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 16, 2019
  • PAGES：174
  • REPORT CODE：GMM325947
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biological Drug Api Manufacturing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Biological Drug Api Manufacturing Market Segmentations:

    By Player:

    • Samsung BioLogics

    • Lonza

    • DSM Biologics

    • Celltrion

    • FUJIFILM Diosynth Biotechnologies

    • Boehringer Ingelheim BioXcellence

    By Type:

    • Monoclonal antibodies (mAbs)

    • Insulin

    • Vaccines

    • Interferons

    • Human growth hormones

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biological Drug Api Manufacturing Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Monoclonal antibodies (mAbs) from 2014 to 2026

    • 1.3.2 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Insulin from 2014 to 2026

    • 1.3.3 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Vaccines from 2014 to 2026

    • 1.3.4 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Interferons from 2014 to 2026

    • 1.3.5 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Human growth hormones from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biological Drug Api Manufacturing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biological Drug Api Manufacturing by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal antibodies (mAbs)

      • 3.4.2 Market Size and Growth Rate of Insulin

      • 3.4.3 Market Size and Growth Rate of Vaccines

      • 3.4.4 Market Size and Growth Rate of Interferons

      • 3.4.5 Market Size and Growth Rate of Human growth hormones

    4 Segmentation of Biological Drug Api Manufacturing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biological Drug Api Manufacturing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biological Drug Api Manufacturing for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Biological Drug Api Manufacturing for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Biological Drug Api Manufacturing for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Biological Drug Api Manufacturing Production Analysis by Top Regions

    • 5.2 Europe Biological Drug Api Manufacturing Consumption Analysis by Top Regions

    • 5.3 Europe Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.3 France Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biological Drug Api Manufacturing Market among Top Countries

    • 6.1 Top 5 Export Countries in Biological Drug Api Manufacturing Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biological Drug Api Manufacturing Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Biological Drug Api Manufacturing Landscape Analysis

    • 7.1 Germany Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 7.2 Germany Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    8. UK Biological Drug Api Manufacturing Landscape Analysis

    • 8.1 UK Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 8.2 UK Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    9. France Biological Drug Api Manufacturing Landscape Analysis

    • 9.1 France Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 9.2 France Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    10. Italy Biological Drug Api Manufacturing Landscape Analysis

    • 10.1 Italy Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 10.2 Italy Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    11. Spain Biological Drug Api Manufacturing Landscape Analysis

    • 11.1 Spain Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 11.2 Spain Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    12. Poland Biological Drug Api Manufacturing Landscape Analysis

    • 12.1 Poland Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 12.2 Poland Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    13. Russia Biological Drug Api Manufacturing Landscape Analysis

    • 13.1 Russia Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 13.2 Russia Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    14. Switzerland Biological Drug Api Manufacturing Landscape Analysis

    • 14.1 Switzerland Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 14.2 Switzerland Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    15. Turkey Biological Drug Api Manufacturing Landscape Analysis

    • 15.1 Turkey Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 15.2 Turkey Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Landscape Analysis by Top Countries

      • 16.3.1 Denmark Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 16.3.2 Finland Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 16.3.3 Norway Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 16.3.4 Sweden Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 16.3.6 Iceland Biological Drug Api Manufacturing Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Landscape Analysis by Top Countries

      • 17.3.1 Belgium Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 17.3.2 Netherlands Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 17.3.3 Luxembourg Biological Drug Api Manufacturing Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Landscape Analysis by Top Countries

      • 18.3.1 Estonia Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 18.3.2 Latvia Biological Drug Api Manufacturing Market Volume and Growth Rate

      • 18.3.3 Lithuania Biological Drug Api Manufacturing Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Samsung BioLogics

      • 19.1.1 Samsung BioLogics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Lonza

      • 19.2.1 Lonza Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 DSM Biologics

      • 19.3.1 DSM Biologics Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Celltrion

      • 19.4.1 Celltrion Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 FUJIFILM Diosynth Biotechnologies

      • 19.5.1 FUJIFILM Diosynth Biotechnologies Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Boehringer Ingelheim BioXcellence

      • 19.6.1 Boehringer Ingelheim BioXcellence Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 66 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Monoclonal antibodies (mAbs) from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Insulin from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Vaccines from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Interferons from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of Human growth hormones from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Biological Drug Api Manufacturing Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure France Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Biological Drug Api Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biological Drug Api Manufacturing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biological Drug Api Manufacturing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biological Drug Api Manufacturing by Different Types from 2014 to 2026

    • Table Consumption Share of Biological Drug Api Manufacturing by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Monoclonal antibodies (mAbs)

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Vaccines

    • Figure Market Size and Growth Rate of Interferons

    • Figure Market Size and Growth Rate of Human growth hormones

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biological Drug Api Manufacturing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biological Drug Api Manufacturing by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Biological Drug Api Manufacturing Production by Major Regions

    • Table Europe Biological Drug Api Manufacturing Production Share by Major Regions

    • Figure Europe Biological Drug Api Manufacturing Production Share by Major Countries and Regions in 2014

    • Table Europe Biological Drug Api Manufacturing Consumption by Major Regions

    • Table Europe Biological Drug Api Manufacturing Consumption Share by Major Regions

    • Table Germany Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table UK Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table France Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Italy Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Spain Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Poland Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Russia Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Switzerland Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Turkey Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biological Drug Api Manufacturing Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Germany Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Germany Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Germany Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table UK Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table UK Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table UK Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table UK Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table France Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table France Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table France Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table France Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Italy Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Italy Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Italy Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Italy Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Spain Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Spain Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Spain Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Spain Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Poland Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Poland Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Poland Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Poland Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Russia Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Russia Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Russia Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Russia Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Switzerland Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Switzerland Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Switzerland Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Turkey Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Turkey Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Turkey Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biological Drug Api Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biological Drug Api Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biological Drug Api Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Biological Drug Api Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Samsung BioLogics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung BioLogics

    • Figure Sales and Growth Rate Analysis of Samsung BioLogics

    • Figure Revenue and Market Share Analysis of Samsung BioLogics

    • Table Product and Service Introduction of Samsung BioLogics

    • Table Company Profile and Development Status of Lonza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza

    • Figure Sales and Growth Rate Analysis of Lonza

    • Figure Revenue and Market Share Analysis of Lonza

    • Table Product and Service Introduction of Lonza

    • Table Company Profile and Development Status of DSM Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DSM Biologics

    • Figure Sales and Growth Rate Analysis of DSM Biologics

    • Figure Revenue and Market Share Analysis of DSM Biologics

    • Table Product and Service Introduction of DSM Biologics

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of FUJIFILM Diosynth Biotechnologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FUJIFILM Diosynth Biotechnologies

    • Figure Sales and Growth Rate Analysis of FUJIFILM Diosynth Biotechnologies

    • Figure Revenue and Market Share Analysis of FUJIFILM Diosynth Biotechnologies

    • Table Product and Service Introduction of FUJIFILM Diosynth Biotechnologies

    • Table Company Profile and Development Status of Boehringer Ingelheim BioXcellence

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim BioXcellence

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim BioXcellence

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim BioXcellence

    • Table Product and Service Introduction of Boehringer Ingelheim BioXcellence

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US